Facebook Instagram X-twitter Linkedin

Cerebrolysin (60mg)

Table of Contents

  • Quickstart Highlights

Cerebrolysin (60mg) protocols focus on this neuropeptide-based compound studied for its potential to support brain health, cognitive function, and neuronal repair. It contains a mixture of low-molecular-weight peptides and amino acids that may promote neuroprotection and neuroplasticity. This guide outlines an intramuscular (IM) or intravenous (IV) administration approach tailored to the 60 mg format.

  • Administration: Intramuscular (IM) or intravenous (IV) injection
  • Typical dosing range: 5–30 mg per day, depending on protocol
  • Cycle length: Commonly used in cycles of 10–20 days
  • Storage: Store refrigerated at 2–8 °C; protect from light and do not freeze
  • Protocol Overview

Concise summary of the administration regimen.

  • Goal: Support cognitive function, neuroprotection, and recovery
  • Schedule: Daily administration during active cycle
  • Dose Range: 5–30 mg per day
  • Cycle Duration: 10–20 days, followed by a break period
  • Dosing Protocol

Suggested approach for the 60 mg format.

  • Start: 5–10 mg per day to assess tolerance
  • Target: 10–30 mg per day, depending on desired outcome
  • Frequency: Once daily (IM or IV)
  • Vial Usage: One 60 mg vial may cover multiple doses depending on protocol
  • Timing: Morning administration preferred for cognitive support
  • Mechanism of Action

Cerebrolysin is a peptide preparation derived from porcine brain proteins, containing biologically active neuropeptides that can cross the blood–brain barrier. It is believed to mimic the action of endogenous neurotrophic factors such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).

These peptides may support neuronal survival, enhance synaptic plasticity, and promote neurogenesis. Additionally, Cerebrolysin may reduce oxidative stress and excitotoxicity, which are associated with neurodegenerative conditions and brain injury. Its multimodal action has been explored in both preclinical and clinical research settings.

  • Potential Benefits & Side Effects

Observations based on clinical and early-stage research.

Potential Benefits:

  • May enhance memory, focus, and cognitive performance
  • May support recovery after neurological injury (e.g., stroke, TBI)
  • May promote neuroprotection and brain cell repair
  • Potential improvement in mental clarity and mood

Possible Side Effects:

  • Generally well tolerated in clinical settings
  • Mild headache, dizziness, or agitation in some users
  • Injection-site discomfort (IM)
  • Rare cases of flushing or sweating
  • Long-term use should be medically supervised